ArticleAnnals of hematology2019

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.

Young-Woo Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.